<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chauvierre C</submitter><funding>ANR</funding><funding>FP7 Health</funding><pagination>E699</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6949921</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(12)</volume><pubmed_abstract>The adhesion molecule P-selectin is present on the cell surface of both activated endothelium and activated platelets. The present study describes the pharmaceutical development, safety evaluation, and preclinical efficacy of a micro-dosed radiotracer. The macromolecular nanoscale assembly consisted of a natural compound made of a sulfated fucose-rich polysaccharides (fucoidan) and a radionuclide (technetium-99m) for the detection of P-selectin expression in cardiovascular diseases. After extraction and fractionation from brown seaweeds, the good manufacturing practice (GMP) production of a low molecular weight (LMW) fucoidan of 7 kDa was achieved and full physicochemical characterization was performed. The regulatory toxicology study in rats of the GMP batch of LMW fucoidan revealed no ad</pubmed_abstract><journal>Marine drugs</journal><pubmed_title>Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.</pubmed_title><pmcid>PMC6949921</pmcid><funding_grant_id>FP7-NMP-2012-LARGE-6-309820</funding_grant_id><funding_grant_id>ANR-13-LAB1-0005-01</funding_grant_id><pubmed_authors>Chauvierre C</pubmed_authors><pubmed_authors>Rolland L</pubmed_authors><pubmed_authors>Chaubet F</pubmed_authors><pubmed_authors>Bussi S</pubmed_authors><pubmed_authors>Zheng KH</pubmed_authors><pubmed_authors>Chollet L</pubmed_authors><pubmed_authors>Aid-Launais R</pubmed_authors><pubmed_authors>Chahid Y</pubmed_authors><pubmed_authors>Le Guludec D</pubmed_authors><pubmed_authors>Bonafe R</pubmed_authors><pubmed_authors>Rossi S</pubmed_authors><pubmed_authors>Stroes ESG</pubmed_authors><pubmed_authors>Fulop T</pubmed_authors><pubmed_authors>Szebeni J</pubmed_authors><pubmed_authors>Dezsi L</pubmed_authors><pubmed_authors>Rouzet F</pubmed_authors><pubmed_authors>Maire M</pubmed_authors><pubmed_authors>Cabella C</pubmed_authors><pubmed_authors>Aerts J</pubmed_authors><pubmed_authors>Letourneur D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.</name><description>The adhesion molecule P-selectin is present on the cell surface of both activated endothelium and activated platelets. The present study describes the pharmaceutical development, safety evaluation, and preclinical efficacy of a micro-dosed radiotracer. The macromolecular nanoscale assembly consisted of a natural compound made of a sulfated fucose-rich polysaccharides (fucoidan) and a radionuclide (technetium-99m) for the detection of P-selectin expression in cardiovascular diseases. After extraction and fractionation from brown seaweeds, the good manufacturing practice (GMP) production of a low molecular weight (LMW) fucoidan of 7 kDa was achieved and full physicochemical characterization was performed. The regulatory toxicology study in rats of the GMP batch of LMW fucoidan revealed no ad</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-04T11:07:00.546Z</modification><creation>2020-05-22T08:00:08Z</creation></dates><accession>S-EPMC6949921</accession><cross_references><pubmed>31842319</pubmed><doi>10.3390/md17120699</doi></cross_references></HashMap>